SARS-CoV-2 immunogenicity at the crossroads

被引：24
|
作者：
Karamloo, Fariba [1 ]
Koenig, Renate [2 ,3 ]
机构：
[1] Paul Ehrlich Inst, Div Haematol Transfus Med, Langen, Germany
[2] Paul Ehrlich Inst, Host Pathogen Interact, Langen, Germany
[3] Sanford Burnham Prebys Med Discovery Inst, Immun & Pathogenesis Program, La Jolla, CA USA
来源：
ALLERGY | 2020年 / 75卷 / 07期
关键词：
infections; inflammation; lung diseases other than asthma and COPD; vaccines; virus;
D O I：
10.1111/all.14360
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1822 / 1824
页数：3
相关论文
共 50 条
  • [1] Immunogenicity of SARS-CoV-2 vaccines in with cancer
    Kakkassery, Helen
    Carpenter, Esme
    Patten, Piers E. M.
    Irshad, Sheeba
    TRENDS IN MOLECULAR MEDICINE, 2022, 28 (12) : 1082 - 1099
  • [2] Immunogenicity of SARS-CoV-2 Vaccine in Dialysis
    Lacson, Eduardo, Jr.
    Argyropoulos, Christos P.
    Manley, Harold J.
    Aweh, Gideon
    Chin, Andrew I.
    Salman, Loay H.
    Hsu, Caroline M.
    Johnson, Doug S.
    Weiner, Daniel E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (11): : 2735 - 2742
  • [3] The Influence of Radioligand Therapy on Immunogenicity against SARS-CoV-2
    Kramer, Carsten
    Eismant, Aleksandr
    Mishra, Aditi
    Mueller, Corinna
    Landvogt, Christian
    Baum, Richard P.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [4] Safety and Immunogenicity of SARS-CoV-2 vaccines in people with HIV
    Gonzalez de Aledo, Manuel
    Canizares, Angelina
    Vazquez-Rodriguez, Pilar
    Castro, Angeles
    Moldes, Luz
    Lopez, Soledad
    Miguez, Enrique
    Bou, German
    Mena, Alvaro
    AIDS, 2022, 36 (05) : 691 - 695
  • [5] Immunogenicity of SARS-CoV-2 vaccine in patients with multiple myeloma
    Malard, Florent
    Gaugler, Beatrice
    Gozlan, Joel
    Bouquet, Lucie
    Fofana, Djeneba
    Van De Wyngaert, Zoe
    Ikhlef, Souhila
    Marjanovitch, Zora
    Morand-Joubert, Laurence
    Mohty, Mohamad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S117 - S117
  • [6] Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine
    Zeng, Guangting
    LANCET MICROBE, 2022, 3 (08): : E561 - E561
  • [7] Immunogenicity and safety of SARS-CoV-2 vaccine with immunosuppressive agents
    Kamei, Koichi
    Ogura, Masao
    Sato, Mai
    Nishi, Kentaro
    Shoji, Kensuke
    Funaki, Takanori
    Ogimi, Chikara
    Ito, Shuichi
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [8] Immunogenicity of SARS-CoV-2 vaccination in adolescents with cardiac disease
    Hayashi, Hiroki
    Narita, Jun
    Ishii, Ryo
    Hirose, Masaki
    Hashimoto, Kazuhisa
    Yamagishi, Yoshiaki
    Ozono, Keiichi
    Nakagami, Hironori
    Ishida, Hidekazu
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [9] Comment on the immunogenicity of the Noora vaccine against SARS-CoV-2
    Forthal, Donald N.
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (05)
  • [10] Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer
    Denault, Elyssa
    Nakajima, Erika
    Naranbhai, Vivek
    Hutchinson, Jennifer A.
    Mortensen, Lindsey
    Neihoff, Elizabeth
    Barabell, Caroline
    Comander, Amy
    Juric, Dejan
    Kuter, Irene
    Mulvey, Theresa
    Peppercorn, Jeffrey
    Rosenstock, Aron S.
    Shin, Jennifer
    Vidula, Neelima
    Wander, Seth A.
    Moy, Beverly
    Ellisen, Leif W.
    Isakoff, Steven J.
    Iafrate, A. John
    Gainor, Justin F.
    Bardia, Aditya
    Spring, Laura M.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
12345